Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 505 (miR-505) is a small, non-coding RNA belonging to the microRNA family, involved in the post-transcriptional regulation of gene expression by binding to target mRNAs and inhibiting their translation or promoting their degradation. It is frequently downregulated in multiple cancer types, where it functions as a tumor suppressor. miR-505 inhibits cancer cell proliferation, migration, invasion, and metabolic reprogramming by targeting several oncogenes such as IGF-1R, HK2, CDK5, and others. Restoring miR-505 expression in tumor models suppresses malignancy and sensitizes cells to chemotherapy. Low miR-505 levels are associated with advanced disease stage, metastasis, and worse overall survival, highlighting its relevance as a prognostic marker and potential therapeutic target.
Tumor suppression by direct targeting and inhibition of oncogenes (e.g., IGF-1R, HK2, HMGB1, CDK5, TGF-α, FZD4, WNT7B, MAP3K3, NRCAM, RUNX2); Interfering with signaling pathways involved in cell proliferation, metabolism, and survival
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 505 (miR-505).